To determine what the extent of THZ1 anti-lymphoma activity is due to STAT3 inhibition, we treated OCI-Ly12 and OCI-Ly13.2 cells with selective STAT3 inhibitor compounds. The gene discussed is STAT3; the disease is lymphoma.